HRMY vs ORCL · P/E 14, rev $476.7M vs P/E 31, rev $67.36B
Harmony Biosciences Holdings (HRMY) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Michael D. Sicilia.
Latest reported HRMY revenue for 2026-06-30 was $476.7M. Net income was $107.9M. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
HRMY currently screens at market cap $1.96B and trailing P/E 13.6. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the HRMY and ORCL stock pages for the full models.
Not investment advice.